We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 541

Augmented Reality
  • McDermott Will & Emery
  • USA
  • August 25 2016

If you haven’t heard about newest gaming craze yet, it’s based on what is called “augmented reality” (AR) and it could potentially impinge on your


Managing the Transition to Transformation: ProviderPayor Integration: 2016 Is Not the 1990s
  • McDermott Will & Emery
  • USA
  • August 17 2016

McDermott’s Managing the Transition to Transformation series is designed to help health systems and other health care industry leaders address the


Governance Oversight of Cybersecurity
  • McDermott Will & Emery
  • USA
  • August 16 2016

Most health system governing boards have some basic awareness of the cybersecurity issues that confront their organizations. Two recent developments


Does Digital Health Need Reimbursement?
  • McDermott Will & Emery
  • USA
  • August 16 2016

One of the most talked about topics when it comes to digital health is the reimbursement under various third-party payer programs. Most notably


FDA and OHRP Issue Joint Draft Guidance on IRB Written Procedures
  • McDermott Will & Emery
  • USA
  • August 15 2016

On August 2, 2016, the US Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) jointly issued draft guidance


FDA Publishes Long-Awaited Draft Guidance on 510(k) Requirements for Modified Devices
  • McDermott Will & Emery
  • USA
  • August 10 2016

On August 5, 2016, the US Food and Drug Administration (FDA) posted two long-awaited draft guidance documents intended to help industry and FDA staff


Guidance on Ransomware Attacks under HIPAA and State Data Breach Notification Laws
  • McDermott Will & Emery
  • USA
  • August 8 2016

US Department of Health and Human Services (HHS) has recently issued guidance under the Health Insurance Portability and Accountability Act (HIPAA) on


FDA Finalizes Guidance on Low Risk General Wellness Devices
  • McDermott Will & Emery
  • USA
  • August 3 2016

On July 29, 2016, the US Food and Drug Administration (FDA) finalized General Wellness: Policy for Low Risk Devices Guidance (Final Guidance


Proposed Changes to Form 5500 Would Significantly Increase Reporting Obligations for Health and Welfare Plan Sponsors
  • McDermott Will & Emery
  • USA
  • August 1 2016

On July 11, 2016, the Department of Labor (DOL) and Internal Revenue Service (IRS) announced a proposal to implement significant changes to the forms


The Whole Claim Is More Inventive Than the Sum of Its Generic Parts
  • McDermott Will & Emery
  • USA
  • July 26 2016

Addressing the issue of subject matter eligibility, the US Court of Appeals for the Federal Circuit reversed the district court's finding that the